Engaging with quality improvement in anticoagulation management

Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation

(2014) Anne-Sophie Larock et al.   ANNALS OF PHARMACOTHERAPY

National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

(2014) Jeffrey S. Dlott et al.   CIRCULATION

Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant

(2014) Morten Lamberts et al.   CIRCULATION

Improving Quality Measurement for Anticoagulation

(2014) Zayd Razouki et al.  

Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention

(2014) Willem J.M. Dewilde et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study

(2014) Jonatan D. Lindh et al.   PLoS One

Comparing patient-level and site-level anticoagulation control as predictors of adverse events

(2014) Ramon S. Cancino et al.   THROMBOSIS RESEARCH

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†

(2013) Hein Heidbuchel et al.   EUROPEAN HEART JOURNAL

The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate

(2013) S. Ibrahim et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)

(2013) Geoffrey D. Barnes et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Nonadherence with INR Monitoring and Anticoagulant Complications

(2013) Daniel M. Witt et al.   THROMBOSIS RESEARCH

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

(2013) Rikke Sørensen et al.   BMJ Open

Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

(2013) Benjamin A. Steinberg et al.   Journal of the American Heart Association

Quality of life and economic costs associated with postthrombotic syndrome

(2012) S. Kachroo et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Evidence-Based Management of Anticoagulant Therapy

(2012) Anne Holbrook et al.   CHEST

National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011

(2012) Kate Kirley et al.  

Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study

(2012) R. S. CHITSIKE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bleeding Risk with Dabigatran in the Frail Elderly

(2012) Paul Harper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

(2011) Michael R. Jaff et al.   CIRCULATION

The Business Case for Quality Improvement

(2011) Adam J. Rose et al.  

Quality measures and benchmarking for warfarin therapy

(2011) Daniel M. Witt   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation

(2011) Marcus Lind et al.   THROMBOSIS RESEARCH

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?

(2009) Daniel E. Singer et al.  

Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

(2008) M. A. Rodger et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2008) et al.   CIRCULATION